A
AGILENT TECHNOLOGIES, INC.
+2.57 (+1.68%)156.27USD478K成交股數44.1B市值30.8本益比(近四季)6.0股價營收比+8.1%營收年增(近四季)2026-11-25下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 10 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 1.9B+8% | 1.8B+10% | 1.8B+7% | 1.9B+18% | 1.7B+10% | 1.7B+1% | 1.7B-0% | 1.6B-6% | 1.6B | 1.7B | 1.7B | 1.7B |
| 營業成本 | 836M | 845M | 852M | 871M | 850M | 802M | 782M | 723M | 717M | 750M | 773M | 1.0B |
| 毛利 | 1.0B+17% | 990M+14% | 946M+5% | 990M+16% | 888M+4% | 866M-5% | 899M-2% | 855M+30% | 856M | 908M | 915M | 658M |
| 毛利率 | 55.5% | 54.0% | 52.6% | 53.2% | 51.1% | 51.9% | 53.5% | 54.2% | 54.4% | 54.8% | 54.2% | 39.4% |
| 研發費用 | 123M | 126M | 117M | 119M | 111M | 112M | 113M | 127M | 113M | 128M | 114M | 118M |
| 銷售管理費用 | 475M | 465M | 476M | 428M | 417M | 454M | 410M | 395M | 380M | 396M | 393M | 407M |
| 營業利益 | 444M+23% | 399M+33% | 353M-6% | 443M+33% | 360M-1% | 300M-22% | 376M-8% | 333M+150% | 363M | 384M | 408M | 133M |
| 營業利益率 | 23.6% | 21.7% | 19.6% | 23.8% | 20.7% | 18.0% | 22.4% | 21.1% | 23.1% | 23.2% | 24.2% | 8.0% |
| 稅後淨利 | 362M+8% | 339M+58% | 305M-4% | 434M+54% | 336M+9% | 215M-38% | 318M-33% | 282M+154% | 308M | 348M | 475M | 111M |
| 淨利率 | 19.3% | 18.5% | 17.0% | 23.3% | 19.3% | 12.9% | 18.9% | 17.9% | 19.6% | 21.0% | 28.1% | 6.6% |
| 稀釋 EPS | 1.28+8% | 1.20+60% | 1.07-4% | 1.53+58% | 1.18+12% | 0.75-36% | 1.11-31% | 0.97+155% | 1.05 | 1.18 | 1.60 | 0.38 |
| 稀釋股數 | 283M | 283M | 284M | 285M | 285M | 285M | 287M | 291M | 293M | 294M | 296M | 295M |
資產負債表 期末餘額
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 1.8B | 1.8B | 1.8B | 1.8B | 1.5B | 1.5B | 1.5B | 1.8B | 1.7B | 1.7B | 1.6B | 1.3B |
| 應收帳款 | 1.5B | 1.5B | 1.5B | 1.5B | 1.4B | 1.4B | 1.3B | 1.2B | 1.2B | 1.3B | 1.3B | 1.3B |
| 存貨 | 1.1B | 1.1B | 1.1B | 1.0B | 1.0B | 991M | 997M | 978M | 1.0B | 1.0B | 1.0B | 1.1B |
| 總資產 | 14.0B | 13.1B | 12.8B | 12.7B | 12.2B | 12.2B | 11.9B | 11.0B | 10.9B | 10.9B | 10.8B | 10.7B |
| 有息負債 | 3.6B | 3.1B | 3.1B | 3.1B | 3.4B | 3.3B | 3.3B | 2.1B | 2.1B | 2.6B | 2.7B | 2.7B |
| 總負債 | 6.6B | 5.9B | 5.9B | 6.0B | 5.9B | 6.0B | 5.9B | 5.1B | 4.6B | 4.8B | 4.9B | 5.1B |
| 股東權益 | 7.4B | 7.1B | 6.9B | 6.7B | 6.4B | 6.1B | 6.0B | 5.9B | 6.2B | 6.2B | 5.8B | 5.6B |
| 負債比 | 47.3% | 45.5% | 46.1% | 47.0% | 47.9% | 49.5% | 49.4% | 46.3% | 42.8% | 43.5% | 45.7% | 47.9% |
| 淨現金(現金 − 有息負債) | −1.9B | −1.2B | −1.3B | −1.3B | −1.8B | −1.9B | −1.9B | −358M | −465M | −807M | −1.1B | −1.4B |
現金流量表 單季
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | – | 268M-38% | – | – | – | 431M | – | – | 485M | – | – |
| 資本支出 | – | – | 93.0M | – | – | – | 97.0M | – | – | 90.0M | – | – |
| 自由現金流 | – | – | 175M-48% | – | – | – | 334M | – | – | 395M | – | – |
| 折舊攤銷 | – | – | 67.0M | – | – | – | 72.0M | – | – | 62.0M | – | – |
| 買回庫藏股 | – | – | 152M | – | – | – | 90.0M | – | – | 0.00 | – | – |
| 現金股利 | 72.0M | 72.0M | 72.0M | 70.0M | 71.0M | 70.0M | 71.0M | 68.0M | 69.0M | 69.0M | 66.0M | 66.0M |
| 自由現金流率 | – | – | 9.7% | – | – | – | 19.9% | – | – | 23.8% | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 6.9B
| Agilent Cross Lab | 2.9B | 41.9% | +5.9% |
|---|---|---|---|
| Life Sciences And Diagnostics Markets | 2.7B | 39.2% | +10.5% |
| Applied Markets | 1.3B | 18.9% | +1.3% |
地區2025 年度 · 13.9B
| 其他地區 | 3.4B | 24.3% | +11.0% |
|---|---|---|---|
| 美洲 | 2.8B | 20.2% | +9.1% |
| 美國 | 2.3B | 16.9% | +4.3% |
| 亞太 | 2.2B | 16.0% | +2.4% |
| 歐洲 | 1.9B | 13.8% | +8.6% |
| 中國 | 1.2B | 8.8% | +0.6% |
產品／服務2025 年度 · 13.9B
| 產品 | 4.9B | 35.6% | +5.8% |
|---|---|---|---|
| Non Instrumentationand Other | 4.5B | 32.5% | +8.8% |
| Instrumentation | 2.4B | 17.5% | +3.1% |
| Service Other | 2.0B | 14.4% | +9.0% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 6.9B | +6.7% | 1.3B | 18.8% | 4.57 | 1.2B |
| FY2024 | 6.5B | -4.7% | 1.3B | 19.8% | 4.43 | 1.4B |
| FY2023 | 6.8B | -0.2% | 1.2B | 18.1% | 4.19 | 1.5B |
| FY2022 | 6.8B | +8.4% | 1.3B | 18.3% | 4.18 | 1.0B |
| FY2021 | 6.3B | +18.4% | 1.2B | 19.1% | 3.94 | 1.3B |
| FY2020 | 5.3B | +3.4% | 719M | 13.5% | 2.30 | 802M |
| FY2019 | 5.2B | +5.1% | 1.1B | 20.7% | 3.37 | 866M |
| FY2018 | 4.9B | – | 316M | 6.4% | 0.97 | 910M |